P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer
Ryohei Katayama(Japanese Foundation For Cancer Research), Naoya Fujita(Japanese Foundation For Cancer Research)
Cited by 140
Related Papers
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer
|Nature Communications|2017|409
Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2
|PLoS ONE|2013|207
The Platelet Aggregation-Inducing Factor Aggrus/Podoplanin Promotes Pulmonary Metastasis
|American Journal Of Pathology|2007|181
Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance
|EBioMedicine|2019|125
A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis
|Scientific Reports|2017|114